HEALTHSTAT NEWS
STAT+: Cadence raises $100 million to automate chronic disease care with regulated AI
Cadence, a digital health company, raised $100 million in funding led by Spark Capital, valuing the company at $1.23 billion. The investment aims to expand Cadence's chronic disease management programs and automate clinician work with AI, despite scrutiny over its billing model from the federal health department's watchdog and insurers like UnitedHealthcare.
Mentioned
Related Signal
Adjacent reporting
- STAT+: CREATE Medicines, a biotech company developing CAR-T therapies, raises $122 million
- Heart Health Biotech Kardigan Raises $400 Million in Upsized IPO
- Novo-Backed Drugmaker Avalyn Raises $300 Million in Upsized IPO
- Novo-Backed Biotech Hemab Seeks to Raise $212 Million in US IPO
- STAT+: Longevity startup Retro Biosciences says latest fundraising values it at $1.8 billion
- Salmon raises $100M in equity and debt to bring digital credit to underbanked Filipinos